CVR number 32302653
Industry 86.9020 Other human health activities

Autoriserede fysioterapeuter Charlottenlund Fysioterapi ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  1.2% 1.0% 1.7% 2.3% 1.9%  
Credit score (0-100)  82 85 71 65 69  
Credit rating  A A A BBB A  
Credit limit (kDKK)  35.0 86.7 1.0 0.0 0.3  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  4,959 3,997 4,717 4,879 5,379  
EBITDA  1,029 996 853 776 889  
EBIT  573 528 124 122 283  
Pre-tax profit (PTP)  357.5 333.5 -32.6 -297.6 -407.8  
Net earnings  278.6 256.2 -25.7 -162.8 -317.7  
Pre-tax profit without non-rec. items  358 333 -32.6 -298 -408  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  441 292 125 33.2 16.6  
Shareholders equity total  488 744 257 94.4 -223  
Interest-bearing liabilities  10,798 10,596 10,265 10,801 12,872  
Balance sheet total (assets)  14,104 14,102 13,141 12,875 15,250  
Net Debt  10,794 10,596 10,265 10,801 12,872  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  4,959 3,997 4,717 4,879 5,379  
Gross profit growth  2.5% -19.4% 18.0% 3.4% 10.3%  
Employees  11 8 9 11 10  
Employee growth %  0.0% -27.3% 12.5% 22.2% -9.1%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  14,104 14,102 13,141 12,875 15,250  
Balance sheet change%  -3.0% -0.0% -6.8% -2.0% 18.5%  
Added value  1,029.5 996.0 853.5 850.9 889.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -2,187 -899 -2,052 -1,308 989  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  11.6% 13.2% 2.6% 2.5% 5.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  4.5% 4.5% 1.9% 1.7% 2.7%  
ROI %  4.9% 5.1% 2.1% 1.8% 2.9%  
ROE %  79.9% 41.6% -5.1% -92.6% -4.1%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  3.5% 5.3% 2.0% 0.7% -1.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  1,048.5% 1,063.8% 1,202.7% 1,392.0% 1,447.5%  
Gearing %  2,212.8% 1,424.0% 3,992.2% 11,447.1% -5,764.0%  
Net interest  0 0 0 0 0  
Financing costs %  2.4% 2.8% 2.8% 4.9% 6.7%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  1.0 1.0 1.2 1.2 0.8  
Current Ratio  1.0 1.0 1.2 1.2 0.8  
Cash and cash equivalent  3.6 0.0 0.0 0.0 0.2  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -17.6 -55.8 689.6 728.0 -1,346.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  94 125 95 77 89  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  94 125 95 71 89  
EBIT / employee  52 66 14 11 28  
Net earnings / employee  25 32 -3 -15 -32